$SDCH
SideChannel Inc

2024 Q1 Form 10-Q Financial Statement

#000149315224005198 Filed on February 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023 Q3
Revenue $1.927M $1.736M $1.659M
YoY Change 19.17% 12.29% -65.35%
Cost Of Revenue $1.059M $891.0K $803.0K
YoY Change 20.34% 30.84% -67.46%
Gross Profit $868.0K $845.0K $856.0K
YoY Change 17.77% -2.31% -63.11%
Gross Profit Margin 45.04% 48.68% 51.6%
Selling, General & Admin $1.005M $978.0K $985.0K
YoY Change -29.57% -26.85% -288.46%
% of Gross Profit 115.78% 115.74% 115.07%
Research & Development $123.0K $126.0K $186.0K
YoY Change -26.79% -6.67% -165.53%
% of Gross Profit 14.17% 14.91% 21.73%
Depreciation & Amortization $2.000K
YoY Change -95.65%
% of Gross Profit 0.23%
Operating Expenses $1.128M $1.104M $1.171M
YoY Change -29.28% -25.0% -245.2%
Operating Profit -$260.0K -$259.0K -$315.0K
YoY Change -69.7% -57.33% -110.07%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $8.000K $13.00K $7.000K
YoY Change 300.0% 160.0% -46.15%
Pretax Income -$252.0K -$246.0K -$5.248M
YoY Change -70.56% -59.14% -40.01%
Income Tax $1.000K -$379.0K
% Of Pretax Income
Net Earnings -$253.0K -$246.0K -$4.869M
YoY Change -70.44% -59.14% -45.56%
Net Earnings / Revenue -13.13% -14.17% -293.49%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 -$0.02
COMMON SHARES
Basic Shares Outstanding 222.0M shares 214.6M shares 213.6M shares
Diluted Shares Outstanding 222.8M shares 214.6M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $851.0K $819.0K $1.053M
YoY Change -55.26% -67.92% -65.25%
Cash & Equivalents $851.0K $800.0K $1.100M
Short-Term Investments
Other Short-Term Assets $626.0K $458.0K $561.0K
YoY Change 35.21% 0.88% 12.2%
Inventory
Prepaid Expenses $446.0K $278.0K $381.0K
Receivables $910.0K $868.0K $834.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.387M $2.145M $2.448M
YoY Change -26.8% -40.03% -40.9%
LONG-TERM ASSETS
Property, Plant & Equipment $24.00K $27.00K $30.00K
YoY Change
Goodwill $1.356M $1.356M $1.356M
YoY Change 0.0% 0.0% -3.14%
Intangibles $0.00
YoY Change -100.0%
Long-Term Investments
YoY Change
Other Assets $60.00K $105.0K $150.0K
YoY Change -75.0% -63.16% -54.55%
Total Long-Term Assets $1.440M $1.488M $1.536M
YoY Change -77.97% -77.39% -76.82%
TOTAL ASSETS
Total Short-Term Assets $2.387M $2.145M $2.448M
Total Long-Term Assets $1.440M $1.488M $1.536M
Total Assets $3.827M $3.633M $3.984M
YoY Change -60.94% -64.24% -63.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $498.0K $511.0K $613.0K
YoY Change -34.9% -26.79% -22.01%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $50.00K
YoY Change -100.0% -100.0% 0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.062M $760.0K $954.0K
YoY Change -23.15% -25.27% -17.83%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.062M $760.0K $954.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.062M $760.0K $954.0K
YoY Change -33.33% -38.11% -30.47%
SHAREHOLDERS EQUITY
Retained Earnings -$19.44M -$19.19M -$18.94M
YoY Change 45.16% 53.05% 58.71%
Common Stock $224.0K $222.0K $214.0K
YoY Change 49.33% 48.99% 43.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.765M $2.873M $3.030M
YoY Change
Total Liabilities & Shareholders Equity $3.827M $3.633M $3.984M
YoY Change -60.94% -64.24% -63.0%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$253.0K -$246.0K -$4.869M
YoY Change -70.44% -59.14% -45.56%
Depreciation, Depletion And Amortization $2.000K
YoY Change -95.65%
Cash From Operating Activities $32.00K -$184.0K -$385.0K
YoY Change -104.92% -61.43% -121.4%
INVESTING ACTIVITIES
Capital Expenditures $8.000K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 -$8.000K
YoY Change -100.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -$50.00K 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 32.00K -$184.0K -385.0K
Cash From Investing Activities 0.000 -8.000K
Cash From Financing Activities 0.000 -$50.00K 0.000
Net Change In Cash 32.00K -$234.0K -393.0K
YoY Change -104.92% -50.94% -108.06%
FREE CASH FLOW
Cash From Operating Activities $32.00K -$184.0K -$385.0K
Capital Expenditures $8.000K
Free Cash Flow -$393.0K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 dei Amendment Flag
AmendmentFlag
false
CY2023Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2023Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 dei Entity Central Index Key
EntityCentralIndexKey
0001022505
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q4 SDCH Stock Issued During Period Value For Warrants
StockIssuedDuringPeriodValueForWarrants
usd
CY2023Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2023Q4 SDCH Stock Based Compensation Included In Accounts Payable And Accrued Liabilities
StockBasedCompensationIncludedInAccountsPayableAndAccruedLiabilities
usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2023Q4 dei Document Type
DocumentType
10-Q
CY2023Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q4 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q4 dei Entity File Number
EntityFileNumber
000-28745
CY2023Q4 dei Entity Registrant Name
EntityRegistrantName
SideChannel, Inc.
CY2023Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-0837077
CY2023Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
146 Main Street
CY2023Q4 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 405
CY2023Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
Worcester
CY2023Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2023Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
01608
CY2023Q4 dei City Area Code
CityAreaCode
(508)
CY2023Q4 dei Local Phone Number
LocalPhoneNumber
925-0114
CY2023Q4 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2023Q4 dei Trading Symbol
TradingSymbol
SDCH
CY2023Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q4 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q4 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q4 dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
222028208 shares
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
819000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1053000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
868000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
834000 usd
CY2023Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
180000 usd
CY2023Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
180000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
278000 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
381000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
2145000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
2448000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
1356000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
1356000 usd
CY2023Q4 us-gaap Deferred Costs
DeferredCosts
105000 usd
CY2023Q3 us-gaap Deferred Costs
DeferredCosts
150000 usd
CY2023Q4 us-gaap Assets
Assets
3633000 usd
CY2023Q3 us-gaap Assets
Assets
3984000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
511000 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
613000 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
238000 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
280000 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
50000 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
11000 usd
CY2023Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
11000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
760000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
954000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
760000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
954000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
681000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
681000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
221645310 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
221645310 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
213854781 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
213854781 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
222000 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
214000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21836000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21755000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19185000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18939000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2873000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3030000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3633000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3984000 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1736000 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1546000 usd
CY2023Q4 us-gaap Cost Of Revenue
CostOfRevenue
891000 usd
CY2022Q4 us-gaap Cost Of Revenue
CostOfRevenue
681000 usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
845000 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
865000 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
709000 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1030000 usd
CY2023Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
269000 usd
CY2022Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
307000 usd
CY2023Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
126000 usd
CY2022Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
135000 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
1104000 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
1472000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-259000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-607000 usd
CY2023Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
13000 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-246000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-602000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-246000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-602000 usd
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
214578923 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
214578923 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
148733860 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
148733860 shares
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3030000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
8000 usd
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
86000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-5000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-246000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2873000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
9396000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
9396000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
18000 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
118000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-602000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
8930000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
8930000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-246000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-602000 usd
CY2023Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
48000 usd
CY2022Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
45000 usd
CY2023Q4 us-gaap Share Based Compensation
ShareBasedCompensation
88000 usd
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
115000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
34000 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-42000 usd
CY2023Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-103000 usd
CY2022Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-46000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-101000 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-67000 usd
CY2023Q4 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-42000 usd
CY2022Q4 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-56000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-184000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-477000 usd
CY2023Q4 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
50000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-50000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-234000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-477000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1053000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3030000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
819000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2553000 usd
CY2022Q4 SDCH Stock Based Compensation Included In Accounts Payable And Accrued Liabilities
StockBasedCompensationIncludedInAccountsPayableAndAccruedLiabilities
21000 usd
CY2023Q4 SDCH Shares Issued For Services Non Cash Investing And Financing Activities
SharesIssuedForServicesNonCashInvestingAndFinancingActivities
8000 usd
CY2022Q4 SDCH Shares Issued For Services Non Cash Investing And Financing Activities
SharesIssuedForServicesNonCashInvestingAndFinancingActivities
18000 usd
CY2023Q2 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
2116618 shares
CY2023Q4 SDCH Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Outstanding Weighted Average Exercise Price Tendered
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsOutstandingWeightedAverageExercisePriceTendered
0.36
CY2023Q4 SDCH Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Non Options Outstanding Weighted Average Remaining Contractual Terms Tendered
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsOutstandingWeightedAverageRemainingContractualTermsTendered
P2Y3M
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
43158000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.33
CY2023Q4 SDCH Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y7M20D
CY2023Q4 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_842_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z1Zs8orlIEPl" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_868_zacRT8Q6o51j">Reclassifications</span></span></i></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Certain prior year amounts have been reclassified to be comparable with the current year’s presentation.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"> </span></p>
CY2023Q4 SDCH Percentage Of Accounts Receivable
PercentageOfAccountsReceivable
0.03 pure
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
10000 usd
CY2021Q4 us-gaap Area Of Land
AreaOfLand
500 sqft
CY2021Q4 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
option to renew annually for three (3) twelve (12) month periods through December 2025
CY2021Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
948 usd
CY2021Q4 SDCH Expected Operating Lease Payments
ExpectedOperatingLeasePayments
967 usd
CY2023Q4 us-gaap Earnings Per Share Potentially Dilutive Securities
EarningsPerSharePotentiallyDilutiveSecurities
Potentially dilutive securities of approximately 50.3 million shares were excluded from diluted EPS in the three months ended December 31, 2023, as we had a net loss
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
800000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1100000 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
238000 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
280000 usd
CY2023Q4 SDCH Contract With Customer Liability Revenue Deferred
ContractWithCustomerLiabilityRevenueDeferred
128000 usd
CY2023Q4 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
170000 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
238000 usd
CY2023Q4 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0 usd
CY2023Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.05
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.05
CY2023Q4 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
93000 usd
CY2023Q4 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
8000 shares
CY2023Q4 SDCH Amortisation Of Outstanding Equity
AmortisationOfOutstandingEquity
85000 usd
CY2023Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
545000 usd
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y
CY2023Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5000 usd
CY2022Q4 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
115000 usd
CY2022Q4 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
18000 shares
CY2022Q4 SDCH Amortisation Of Outstanding Equity
AmortisationOfOutstandingEquity
97000 usd
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
221645310 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
681000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
213854781 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
17415437 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.18
CY2023Q4 SDCH Bid Price
BidPrice
0.36
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
43200000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
69281000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.39
CY2023 SDCH Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y3M21D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
17415000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.18
CY2023Q4 SDCH Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Non Options Outstanding Weighted Average Remaining Contractual Terms Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsOutstandingWeightedAverageRemainingContractualTermsGranted
P5Y
CY2023Q4 SDCH Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Tendered
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsTendered
43538000 shares

Files In Submission

Name View Source Status
0001493152-24-005198-index-headers.html Edgar Link pending
0001493152-24-005198-index.html Edgar Link pending
0001493152-24-005198.txt Edgar Link pending
0001493152-24-005198-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sdch-20231231.xsd Edgar Link pending
Show.js Edgar Link pending
sdch-20231231_cal.xml Edgar Link unprocessable
sdch-20231231_def.xml Edgar Link unprocessable
sdch-20231231_pre.xml Edgar Link unprocessable
sdch-20231231_lab.xml Edgar Link unprocessable